Elevated level of neuroserpin is an indication for the resistance to gambogic acid-induced apoptosis and oxidative stress in triple-negative breast cancer cells

[1] Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci. 2017; 151:1–32. WintersS MartinC MurphyD ShokarNK Breast cancer epidemiology, prevention, and screening Prog Mol Biol Transl Sci 2017 151 1 32 Search in Google Scholar

[2] World Health Organization. Projections of mortality and causes of death, 2015 and 2030. 2020. World Health Organization Projections of mortality and causes of death, 2015 and 2030 2020 Search in Google Scholar

[3] Karami Fath M, Azargoonjahromi A, Kiani A, Jalalifar F, Osati P, Akbari Oryani M, et al. The role of epigenetic modifications in drug resistance and treatment of breast cancer. Cell Mol Biol Lett. 2022; 27:52. doi: 10.1186/s11658-022-00344-6 Karami FathM AzargoonjahromiA KianiA JalalifarF OsatiP Akbari OryaniM The role of epigenetic modifications in drug resistance and treatment of breast cancer Cell Mol Biol Lett 2022 27 52 10.1186/s11658-022-00344-6 Open DOISearch in Google Scholar

[4] Wilson TR, Johnston PG, Longley DB. Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets. 2009; 9:307–19. WilsonTR JohnstonPG LongleyDB Anti-apoptotic mechanisms of drug resistance in cancer Curr Cancer Drug Targets 2009 9 307 19 Search in Google Scholar

[5] Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117:927–39. YangJ ManiSA DonaherJL RamaswamyS ItzyksonRA ComeC Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 2004 117 927 39 Search in Google Scholar

[6] Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, Shi B. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015; 5:2929–43. DaiX LiT BaiZ YangY LiuX ZhanJ ShiB Breast cancer intrinsic subtype classification, clinical use and future trends Am J Cancer Res 2015 5 2929 43 Search in Google Scholar

[7] Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007; 13:4429–34. DentR TrudeauM PritchardKI HannaWM KahnHK SawkaCA Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 2007 13 4429 34 Search in Google Scholar

[8] Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019; 321:288–300. WaksAG WinerEP Breast cancer treatment: a review JAMA 2019 321 288 300 Search in Google Scholar

[9] Hanikoglu A, Kucuksayan E, Hanikoglu F, Ozben T, Menounou G, Sansone A, et al. Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes. Can J Physiol Pharmacol. 2020; 98:131–8. HanikogluA KucuksayanE HanikogluF OzbenT MenounouG SansoneA Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes Can J Physiol Pharmacol 2020 98 131 8 Search in Google Scholar

[10] Hanikoglu A, Kucuksayan E, Hanikoglu F, Ozben T, Menounou G, Sansone A, et al. Effects of somatostatin and vitamin C on the fatty acid profile of breast cancer cell membranes. Anticancer Agents Med Chem. 2019; 19:1899–909. HanikogluA KucuksayanE HanikogluF OzbenT MenounouG SansoneA Effects of somatostatin and vitamin C on the fatty acid profile of breast cancer cell membranes Anticancer Agents Med Chem 2019 19 1899 909 Search in Google Scholar

[11] Aung TN, Qu Z, Kortschak RD, Adelson DL. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci. 2017; 18. 656. doi: 10.3390/ijms18030656 AungTN QuZ KortschakRD AdelsonDL Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action Int J Mol Sci 2017 18 656 10.3390/ijms18030656 Open DOISearch in Google Scholar

[12] Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020; 177:1409–23. LinSR ChangCH HsuCF TsaiMJ ChengH LeongMK Natural compounds as potential adjuvants to cancer therapy: preclinical evidence Br J Pharmacol 2020 177 1409 23 Search in Google Scholar

[13] Wang QL, Yang DZ, Lv C. Antiinflammatory effects of gambogic acid in murine collageninduced arthritis through PI3K/Akt signaling pathway. Mol Med Rep. 2018; 17:4791–6. WangQL YangDZ LvC Antiinflammatory effects of gambogic acid in murine collageninduced arthritis through PI3K/Akt signaling pathway Mol Med Rep 2018 17 4791 6 Search in Google Scholar

[14] Pandey MK, Karelia D, Amin SG. Gambogic acid and its role in chronic diseases. Adv Exp Med Biol. 2016; 928:375–95. PandeyMK KareliaD AminSG Gambogic acid and its role in chronic diseases Adv Exp Med Biol 2016 928 375 95 Search in Google Scholar

[15] Pan H, Jansson KH, Beshiri ML, Yin J, Fang L, Agarwal S, et al. Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget. 2017; 8:77181–94. PanH JanssonKH BeshiriML YinJ FangL AgarwalS Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer Oncotarget 2017 8 77181 94 Search in Google Scholar

[16] Zhang L, Yi Y, Chen J, Sun Y, Guo Q, Zheng Z, Song S. Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells. Biochem Biophys Res Commun. 2010; 403:282–7. ZhangL YiY ChenJ SunY GuoQ ZhengZ SongS Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells Biochem Biophys Res Commun 2010 403 282 7 Search in Google Scholar

[17] Tang Q, Lu M, Zhou H, Chen D, Liu L. Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity. Oncol Lett. 2017; 13:384–8. TangQ LuM ZhouH ChenD LiuL Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity Oncol Lett 2017 13 384 8 Search in Google Scholar

[18] Wang X, Chen W. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer Agents Med Chem. 2012; 12:994–1000. WangX ChenW Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis Anticancer Agents Med Chem 2012 12 994 1000 Search in Google Scholar

[19] Kucuksayan E, Sircan-Kucuksayan A. Real-time detection of doxorubicin-induced apoptosis in breast cancer cells using the back reflection spectroscopy. East J Med. 2021; 26:128–34. KucuksayanE Sircan-KucuksayanA Real-time detection of doxorubicin-induced apoptosis in breast cancer cells using the back reflection spectroscopy East J Med 2021 26 128 34 Search in Google Scholar

[20] Kucuksayan E, Cort A, Timur M, Ozdemir E, Yucel SG, Ozben T. N-acetyl-L-cysteine inhibits bleomycin induced apoptosis in malignant testicular germ cell tumors. J Cell Biochem. 2013; 114:1685–94. KucuksayanE CortA TimurM OzdemirE YucelSG OzbenT N-acetyl-L-cysteine inhibits bleomycin induced apoptosis in malignant testicular germ cell tumors J Cell Biochem 2013 114 1685 94 Search in Google Scholar

[21] Betriu N, Semino CE. Development of a 3D co-culture system as a cancer model using a self-assembling peptide scaffold. Gels. 2018; 4:65. doi: 10.3390/gels4030065 BetriuN SeminoCE Development of a 3D co-culture system as a cancer model using a self-assembling peptide scaffold Gels 2018 4 65 10.3390/gels4030065 Open DOISearch in Google Scholar

[22] Wankun X, Wenzhen Y, Min Z, Weiyan Z, Huan C, Wei D, et al. Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro. Mol Vis. 2011; 17:3512–22. WankunX WenzhenY MinZ WeiyanZ HuanC WeiD Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro Mol Vis 2011 17 3512 22 Search in Google Scholar

[23] Kntayya S, Ibrahim M, Mohd Ain N, Iori R, Ioannides C, Abdull Razis A. Induction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 Cells. Nutrients. 2018; 10:718. doi: 10.3390/nu10060718 KntayyaS IbrahimM Mohd AinN IoriR IoannidesC Abdull RazisA Induction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 Cells Nutrients 2018 10 718 10.3390/nu10060718 Open DOISearch in Google Scholar

[24] Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A. 2020; 117:5931–7. NaTY SchectersonL MendonsaAM GumbinerBM The functional activity of E-cadherin controls tumor cell metastasis at multiple steps Proc Natl Acad Sci U S A 2020 117 5931 7 Search in Google Scholar

[25] Nguyen PT, Nguyen D, Chea C, Miyauchi M, Fujii M, Takata T. Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer. Oncotarget. 2018; 9: 31516–30. NguyenPT NguyenD CheaC MiyauchiM FujiiM TakataT Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer Oncotarget 2018 9 31516 30 Search in Google Scholar

[26] Zhao L, Guo QL, You QD, Wu ZQ, Gu HY. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull. 2004; 27:998–1003. ZhaoL GuoQL YouQD WuZQ GuHY Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells Biol Pharm Bull 2004 27 998 1003 Search in Google Scholar

[27] Chang WS, Chang NT, Lin SC, Wu CW, Wu FY. Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26. Genes Chromosomes Cancer. 2000; 29:240–55. ChangWS ChangNT LinSC WuCW WuFY Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26 Genes Chromosomes Cancer 2000 29 240 55 Search in Google Scholar

[28] Hasumi H, Ishiguro H, Nakamura M, Sugiura S, Osada Y, Miyoshi Y, et al. Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival. Int J Cancer. 2005; 115:911–6. HasumiH IshiguroH NakamuraM SugiuraS OsadaY MiyoshiY Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival Int J Cancer 2005 115 911 6 Search in Google Scholar

[29] Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 2014; 156:1002–16. ValienteM ObenaufAC JinX ChenQ ZhangXH LeeDJ Serpins promote cancer cell survival and vascular co-option in brain metastasis Cell 2014 156 1002 16 Search in Google Scholar

[30] Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015; 235:76–84. WangS WangL ChenM WangY Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression Chem Biol Interact 2015 235 76 84 Search in Google Scholar

[31] Shergill K, Sen A, Pillai HJ. Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 2018; 44:182–90. ShergillK SenA PillaiHJ Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma J Korean Assoc Oral Maxillofac Surg 2018 44 182 90 Search in Google Scholar

[32] Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999; 147:631–44. NiemanMT PrudoffRS JohnsonKR WheelockMJ N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression J Cell Biol 1999 147 631 44 Search in Google Scholar

[33] Zhao K, Zhang S, Song X, Yao Y, Zhou Y, You Q, et al. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFbeta1-induced epithelial-to-mesenchymal transition. Oncotarget. 2017; 8:27120–36. ZhaoK ZhangS SongX YaoY ZhouY YouQ Gambogic acid suppresses cancer invasion and migration by inhibiting TGFbeta1-induced epithelial-to-mesenchymal transition Oncotarget 2017 8 27120 36 Search in Google Scholar

[34] Li CY, Wang Q, Wang XM, Li GX, Shen S, Wei XL. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways. Eur J Pharmacol. 2019; 864:172719. doi: 10.1016/j.ejphar.2019.172719 LiCY WangQ WangXM LiGX ShenS WeiXL Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways Eur J Pharmacol 2019 864 172719 10.1016/j.ejphar.2019.172719 Open DOISearch in Google Scholar

[35] Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J. Direct activation of Bax protein for cancer therapy. Med Res Rev. 2016; 36: 313–41. LiuZ DingY YeN WildC ChenH ZhouJ Direct activation of Bax protein for cancer therapy Med Res Rev 2016 36 313 41 Search in Google Scholar

[36] Cetin A, Ozgur A, Kuzucu M, Çankaya M. Investigation of the synergistic effects of trastuzumab and gambogic acid in Her-2 positive breast cancer cell line. Hacettepe J Biol Chem. 2020; 48:291–9. CetinA OzgurA KuzucuM ÇankayaM Investigation of the synergistic effects of trastuzumab and gambogic acid in Her-2 positive breast cancer cell line Hacettepe J Biol Chem 2020 48 291 9 Search in Google Scholar

[37] Duan D, Zhang B, Yao J, Liu Y, Sun J, Ge C, Peng S, Fang J. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase. Free Radic Biol Med. 2014; 69:15–25. DuanD ZhangB YaoJ LiuY SunJ GeC PengS FangJ Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase Free Radic Biol Med 2014 69 15 25 Search in Google Scholar

[38] Cheng Y, Loh YP, Birch NP. Neuroserpin attenuates H(2)O(2)-induced oxidative stress in hippocampal neurons via AKT and BCL-2 signaling pathways. J Mol Neurosci. 2017; 61:123–31. ChengY LohYP BirchNP Neuroserpin attenuates H(2)O(2)-induced oxidative stress in hippocampal neurons via AKT and BCL-2 signaling pathways J Mol Neurosci 2017 61 123 31 Search in Google Scholar

[39] Kaufmann T, Strasser A, Jost PJ. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ. 2012; 19:42–50. KaufmannT StrasserA JostPJ Fas death receptor signalling: roles of Bid and XIAP Cell Death Differ 2012 19 42 50 Search in Google Scholar

[40] Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, et al. Antioxidants for the treatment of breast cancer: are we there yet? Antioxidants. 2021; 10:205. doi: 10.3390/antiox10020205 Griñan-LisonC Blaya-CánovasJL López-TejadaA Ávalos-MorenoM Navarro-OcónA CaraFE Antioxidants for the treatment of breast cancer: are we there yet? Antioxidants 2021 10 205 10.3390/antiox10020205 Open DOISearch in Google Scholar

[41] Rodriguez-Gonzalez R, Sobrino T, Rodriguez-Yanez M, Millan M, Brea D, Miranda E, et al. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med. 2011; 9:58. doi: 10.1186/1479-5876-9-58 Rodriguez-GonzalezR SobrinoT Rodriguez-YanezM MillanM BreaD MirandaE Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke J Transl Med 2011 9 58 10.1186/1479-5876-9-58 Open DOISearch in Google Scholar

[42] Gupta V, Mirzaei M, Gupta VB, Chitranshi N, Dheer Y, Vander Wall R, et al. Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin. Sci Rep. 2017; 7:8412. doi: 10.1038/s41598-017-08688-2 GuptaV MirzaeiM GuptaVB ChitranshiN DheerY Vander WallR Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin Sci Rep 2017 7 8412 10.1038/s41598-017-08688-2 Open DOISearch in Google Scholar

[43] Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res. 2007; 13: 1133–9. JiaHL YeQH QinLX BudhuA ForguesM ChenY Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma Clin Cancer Res 2007 13 1133 9 Search in Google Scholar